(ENTG) Entegris - Ratings and Ratios
Deposition Materials, Slurries, Implant Gases, Etch Chemicals, Filters
Dividends
| Dividend Yield | 0.45% |
| Yield on Cost 5y | 0.42% |
| Yield CAGR 5y | 5.74% |
| Payout Consistency | 98.1% |
| Payout Ratio | 13.8% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 49.6% |
| Value at Risk 5%th | 80.1% |
| Relative Tail Risk | -1.82% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.11 |
| Alpha | -46.08 |
| CAGR/Max DD | 0.16 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.537 |
| Beta | 2.300 |
| Beta Downside | 2.406 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.93% |
| Mean DD | 20.83% |
| Median DD | 17.85% |
Description: ENTG Entegris October 31, 2025
Entegris, Inc. (NASDAQ: ENTG) supplies advanced materials and contamination-control solutions to the semiconductor and broader high-technology sectors across North America, Asia, and Europe, operating through two primary segments: Materials Solutions (MS) and Advanced Purity Solutions (APS).
The MS segment delivers specialty chemicals and consumables-including chemical vapor deposition (CVD) and atomic layer deposition (ALD) precursors, chemical-mechanical planarization (CMP) slurries and pads, ion-implantation gases, and formulated etch/clean materials-supporting wafer fabrication and advanced packaging processes.
APS focuses on filtration, purification, and contamination-control hardware and services that protect critical process equipment and downstream products, serving not only semiconductor fabs but also equipment makers, gas/chemical producers, and wafer growers.
Key customers span logic and memory chipmakers, semiconductor equipment manufacturers, flat-panel display and hard-disk drive suppliers, as well as adjacent markets such as solar, life-science, aerospace, and biomedical device manufacturers.
Recent financial data (FY 2023) show revenue of roughly $2.1 billion, with an operating margin near 13 % and a year-over-year sales increase of about 8 %, driven largely by rising demand for AI-related chips and advanced packaging. The company’s exposure to the semiconductor cycle is moderated by its diversified end-markets and its strategic focus on high-purity filtration, a segment projected to grow at a compound annual rate of 6-8 % through 2028 as fab capacity expands worldwide.
Given Entegris’s position in a supply-chain-critical niche and its solid cash-flow generation, a deeper, data-driven valuation of ENTG can be explored on ValueRay for investors seeking quantitative insight.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (288.4m TTM) > 0 and > 6% of Revenue (6% = 193.4m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 2.83pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 37.37% (prev 35.22%; Δ 2.15pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 679.5m > Net Income 288.4m (YES >=105%, WARN >=100%) |
| Net Debt (3.51b) to EBITDA (897.8m) ratio: 3.91 <= 3.0 (WARN <= 3.5) |
| Current Ratio 3.44 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (152.3m) change vs 12m ago 0.25% (target <= -2.0% for YES) |
| Gross Margin 44.89% (prev 45.08%; Δ -0.19pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 38.19% (prev 37.81%; Δ 0.38pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.58 (EBITDA TTM 897.8m / Interest Expense TTM 199.5m) >= 6 (WARN >= 3) |
Altman Z'' 2.28
| (A) 0.14 = (Total Current Assets 1.70b - Total Current Liabilities 492.7m) / Total Assets 8.40b |
| (B) 0.18 = Retained Earnings (Balance) 1.52b / Total Assets 8.40b |
| (C) 0.06 = EBIT TTM 514.0m / Avg Total Assets 8.44b |
| (D) 0.32 = Book Value of Equity 1.46b / Total Liabilities 4.51b |
| Total Rating: 2.28 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.39
| 1. Piotroski 4.0pt |
| 2. FCF Yield 3.35% |
| 3. FCF Margin 15.68% |
| 4. Debt/Equity 1.00 |
| 5. Debt/Ebitda 3.91 |
| 6. ROIC - WACC (= -4.61)% |
| 7. RoE 7.62% |
| 8. Rev. Trend 21.19% |
| 9. EPS Trend -63.83% |
What is the price of ENTG shares?
Over the past week, the price has changed by +16.86%, over one month by +2.86%, over three months by +8.65% and over the past year by -18.97%.
Is ENTG a buy, sell or hold?
- Strong Buy: 5
- Buy: 3
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ENTG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 100.5 | 12.7% |
| Analysts Target Price | 100.5 | 12.7% |
| ValueRay Target Price | 86 | -3.5% |
ENTG Fundamental Data Overview December 03, 2025
P/E Trailing = 40.1526
P/E Forward = 23.5849
P/S = 3.589
P/B = 3.0057
P/EG = 1.2962
Beta = 1.307
Revenue TTM = 3.22b USD
EBIT TTM = 514.0m USD
EBITDA TTM = 897.8m USD
Long Term Debt = 3.84b USD (from longTermDebt, last quarter)
Short Term Debt = 50.0m USD (from shortTermDebt, two quarters ago)
Debt = 3.91b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.51b USD (from netDebt column, last quarter)
Enterprise Value = 15.07b USD (11.57b + Debt 3.91b - CCE 399.8m)
Interest Coverage Ratio = 2.58 (Ebit TTM 514.0m / Interest Expense TTM 199.5m)
FCF Yield = 3.35% (FCF TTM 505.3m / Enterprise Value 15.07b)
FCF Margin = 15.68% (FCF TTM 505.3m / Revenue TTM 3.22b)
Net Margin = 8.95% (Net Income TTM 288.4m / Revenue TTM 3.22b)
Gross Margin = 44.89% ((Revenue TTM 3.22b - Cost of Revenue TTM 1.78b) / Revenue TTM)
Gross Margin QoQ = 43.53% (prev 44.36%)
Tobins Q-Ratio = 1.79 (Enterprise Value 15.07b / Total Assets 8.40b)
Interest Expense / Debt = 1.18% (Interest Expense 46.1m / Debt 3.91b)
Taxrate = 2.07% (1.50m / 72.3m)
NOPAT = 503.3m (EBIT 514.0m * (1 - 2.07%))
Current Ratio = 3.44 (Total Current Assets 1.70b / Total Current Liabilities 492.7m)
Debt / Equity = 1.00 (Debt 3.91b / totalStockholderEquity, last quarter 3.89b)
Debt / EBITDA = 3.91 (Net Debt 3.51b / EBITDA 897.8m)
Debt / FCF = 6.94 (Net Debt 3.51b / FCF TTM 505.3m)
Total Stockholder Equity = 3.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.43% (Net Income 288.4m / Total Assets 8.40b)
RoE = 7.62% (Net Income TTM 288.4m / Total Stockholder Equity 3.79b)
RoCE = 6.74% (EBIT 514.0m / Capital Employed (Equity 3.79b + L.T.Debt 3.84b))
RoIC = 6.51% (NOPAT 503.3m / Invested Capital 7.73b)
WACC = 11.12% (E(11.57b)/V(15.47b) * Re(14.49%) + D(3.91b)/V(15.47b) * Rd(1.18%) * (1-Tc(0.02)))
Discount Rate = 14.49% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.32%
[DCF Debug] Terminal Value 47.39% ; FCFE base≈411.0m ; Y1≈269.8m ; Y5≈123.4m
Fair Price DCF = 7.83 (DCF Value 1.19b / Shares Outstanding 151.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -63.83 | EPS CAGR: -7.38% | SUE: 0.0 | # QB: 0
Revenue Correlation: 21.19 | Revenue CAGR: 6.60% | SUE: 0.14 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.64 | Chg30d=-0.111 | Revisions Net=-8 | Analysts=10
EPS next Year (2026-12-31): EPS=3.24 | Chg30d=-0.289 | Revisions Net=-12 | Growth EPS=+19.1% | Growth Revenue=+6.1%
Additional Sources for ENTG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle